| Product Specifications | |
| Application | FC |
| Clonality | Monoclonal IgG2b |
| Host | Mouse |
| Immunogen | Carrier protein conjugated synthetic peptide, GKPIPNPLLGLDST (V5-tag) |
| Formulation | 1 mg/mL in PBS/50% glycerol, pH 7.2 |
| Storage | |
| Documents & Links for Anti-V5-tag mAb for My select sampler set (Clone: OZA3) | |
| Datasheet | Anti-V5-tag mAb for My select sampler set (Clone: OZA3) Datasheet |
| Documents & Links for Anti-V5-tag mAb for My select sampler set (Clone: OZA3) | |
| Datasheet | Anti-V5-tag mAb for My select sampler set (Clone: OZA3) Datasheet |
| Citations for Anti-V5-tag mAb for My select sampler set (Clone: OZA3) – 2 Found |
| Sekiya, Takashi; Takaki, Satoshi. RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4. Scientific Reports. 2019;9(1):6984. PubMed - Comments: Used in: WB |
| Sekiya, Takashi; Takaki, Satoshi. RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4. Scientific Reports. 2019;9(1):6984. PubMed - Comments: Used in: WB |